Le Lézard
Classified in: Health
Subjects: MAV, CFG

Media Advisory - Prime Minister's itinerary for Thursday, March 7, 2024


OTTAWA, ON, March 6, 2024 /CNW/ -

Note: All times local

Greater Toronto Area, Ontario


The Prime Minister will meet with nurses and physicians.


Note for media:

  • Pooled photo opportunity

The Prime Minister will make a pharmacare announcement. The Deputy Prime Minister
and Minister of Finance, Chrystia Freeland, and the Minister for Women and Gender
Equality and Youth, Marci Ien, will also be in attendance. A media availability will follow.


Notes for media: 

  • Open coverage
  • Media are asked to arrive no later than 10:30 a.m.
  • Media interested in participating can contact [email protected] for details.

The Prime Minister will meet with health care professionals and non-profit diabetes
advocates.


Note for media:

  • Pooled photo opportunity

This document is also available at https://pm.gc.ca

SOURCE Prime Minister's Office


These press releases may also interest you

at 03:05
MaineGeneral Health in the US selects Sectra's enterprise imaging SaaS to help radiologists improve diagnostic speed despite growing demands
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide US healthcare provider MaineGeneral Health its enterprise imaging as a fully hosted public cloud service, Sectra One Cloud. The comprehensive solution will...

at 03:00
Clarivate Repeats Success in Nobel Prize Predictions with Eight New Winners Identified by Citation Laureates Program
Clarivate Plc , a leading global provider of transformative intelligence, today announced the success of its annual Citation Laureatestm program, following the accurate forecast of eight Nobel Prize 2024 recipients....

at 02:35
Celltrion presents 2-year post-hoc analysis findings for subcutaneous infliximab (CT-P13 SC), highlighting dose escalation as an option for managing loss of response in inflammatory bowel disease
Celltrion today announced two-year results of subcutaneous infliximab (CT-P13 SC) dose escalation therapy at United European Gastroenterology (UEG) Week 2024 in Vienna. The post-hoc analysis from the LIBERTY-CD (Crohn's disease) and LIBERTY-UC...

at 02:35
Almirall Announces Completion of Decentralized Regulatory Approval Procedure for Efinaconazole in Europe
Almirall, S.A. (ALM), a global pharmaceutical company dedicated to medical dermatology announced today the successful completion of the decentralized regulatory procedure in Europe for efinaconazole, a triazole antifungal compound indicated for the...

at 02:05
Diagnosed with Mesothelioma? Mesothelioma Offers Free Legal Connections to Top Attorneys
Mesothelioma, a rare but aggressive cancer caused by exposure to asbestos, affects thousands of individuals each year. For those diagnosed, the challenges can feel overwhelming?not just physically, but also financially and legally. Mesothelioma is...

at 01:35
MaaT Pharma Completes Recruitment of its ARES Phase 3 Trial for MaaT013 to Treat Acute Graft-versus-Host Disease
Regulatory News: MaaT Pharma (EURONEXT: MAAT ? the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer through immune...

More news about Health...


News published on and distributed by: